Keyphrases
Survival Motor Neuron
100%
Non-alcoholic Fatty Liver Disease (NAFLD)
100%
Rapid Onset
100%
Nonalcoholic Steatohepatitis
33%
Steatohepatitis
33%
Microvesicles
33%
Histologic
22%
Growth Factors
11%
Best Model
11%
Adult Population
11%
Liver
11%
Metabolism
11%
Insulin-like
11%
Insulin Resistance
11%
Spinal muscular Atrophy
11%
Proteomics
11%
Gene Therapy
11%
Molecular Markers
11%
Mouse Model
11%
Hypoglycemia
11%
Health Systems
11%
Lipolysis
11%
Early Onset
11%
Disease Pathogenesis
11%
Neurological Conditions
11%
Lose Weight
11%
Fibrosis
11%
Liver Damage
11%
Electron Microscopy
11%
Pediatric Population
11%
Hepatic Steatosis
11%
Reactive Oxygen Species Production
11%
Fatty Liver
11%
Disease Phenotype
11%
Coagulation
11%
Non-esterified Fatty Acids
11%
Fibrogenesis
11%
Molecular Player
11%
Typical Features
11%
Iron Homeostasis
11%
Isolated Mitochondria
11%
Mitochondrial Content
11%
Compensatory Response
11%
Stellate Cell Activation
11%
Mitochondrial Reactive Oxygen Species Production
11%
Hyperglucagonemia
11%
High-resolution Respirometry
11%
Hepatic Mitochondria
11%
Hepatic Dysfunction
11%
Enhanced Oxidation
11%
AAV9
11%
Health Epidemics
11%
Biochemistry, Genetics and Molecular Biology
Motor Neuron
100%
Metabolic Pathway
50%
Insulin-Like Growth Factor 1
50%
Insulin Resistance
50%
Survival of Motor Neuron
50%
Mitochondrion
50%
Electron Microscopy
50%
Genetic Marker
50%
Cell Activation
50%
Mouse Model
50%
Gene Therapy
50%
Lipolysis
50%
Tissue Section
50%
Iron Homeostasis
50%
Fibrogenesis
50%
Stellate Cell
50%
Proteomics
50%
Medicine and Dentistry
Nonalcoholic Fatty Liver
100%
Steatohepatitis
25%
Reactive Oxygen Species
16%
Fatty Liver
16%
Insulin Resistance
8%
Gene Therapy
8%
Mitochondrion
8%
Fatty Acid
8%
Hypoglycemia
8%
Health Care Cost
8%
Cell Activation
8%
Pediatrics
8%
Liver Injury
8%
Fibrosis
8%
Electron Microscopy
8%
Liver Dysfunction
8%
Lipolysis
8%
Spinal Muscular Atrophy
8%
Iron Homeostasis
8%
Hyperglucagonemia
8%
Somatomedin C
8%
Respirometry
8%
Fibrogenesis
8%
Stellate Cell
8%
Proteomics
8%
Molecular Marker
8%
Pharmacology, Toxicology and Pharmaceutical Science
Nonalcoholic Fatty Liver
100%
Reactive Oxygen Metabolite
16%
Fatty Liver
16%
Insulin Resistance
8%
Fatty Acid
8%
Hypoglycemia
8%
Liver Injury
8%
Fibrosis
8%
Mouse Model
8%
Electron Microscopy
8%
Liver Dysfunction
8%
Somatomedin C
8%
Spinal Muscular Atrophy
8%
Hyperglucagonemia
8%
Iron
8%
Molecular Marker
8%